Disease management programs for adults with often diseases and competence networks for children and adolescents with rare diseases;Disease-Management-Programme für Erwachsene mit " volkskrankheiten" und Kompetenznetze für Kinder und Jugendliche mit seltenen Erkrankungen

Klinische Padiatrie

Volumn 223, Issue 1, 2011, Pages 1-3

  Gobel U ^b   Gortner, L ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE MANAGEMENT; HEALTH PROGRAM; HUMAN; RARE DISEASE; REVIEW;

ADOLESCENT; ADULT; CHILD; COOPERATIVE BEHAVIOR; DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; GERMANY; HEMATOLOGIC DISEASES; HUMANS; INTERDISCIPLINARY COMMUNICATION; LIFE STYLE; NEOPLASMS; RARE DISEASES;

EID: 78751671884     PISSN: 03008630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0030-1269936     Document Type: Review

References (26)

1. Calaminus G, Kaatsch P. Position paper of the Society of Pediatric Oncology and Hematology (GPOH) on (long-term) surveillance, (long-term) follow-up and late effect evaluation in pediatric oncology patients. Klin Padiatr 2007 219 173-178
2. Creutzig U, Herold R, Henze G. [Results of the Competence Net Pediatric Oncology and Haematology- a view back]. Klin Padiatr 2010 222 333-336
3. de Sousa G, Hussein A, Trowitzsch E, et al. Hemodynamic responses in obese children and adolescents before and after overweight reduction. Klin Padiatr 2009 221 237-240
4. du Prel JB, Röhrig B, Blettner M. Critical appraisal of scientific articles: part 1 of a series on evaluation of scientific publications. Dtsch Arztebl Int 2009 106 100-105
5. Gerlach FM, Beyer M, Szecsenyi J, et al. Evaluation von Disease-Management-Programmen - Aktuelle Defizite, Anforderungen, Methoden. Z ärztl Fortbild Qual.sich (ZaeFQ) 2003 97 495-501
6. Göbel U, Gortner L. [The journal's development since the introduction of online manuscript submission and the double blinded peer review of manuscripts]. Klin Padiatr 2010 222 231-233
7. Göbel U, Heinrich B, Krauth KA, et al. [Process and outcome quality of the German Paediatric Surveillance Unit (ESPED)]. Klin Padiatr 2010 222 92-97
8. Häussler B, Berger U. Bedingungen für effektive Disease-Management-Programme. Analyse, Bewertung und Lösungsansätze für Qualität und Finanzierung. Nomos Verlagsgesellschaft Baden-Baden 2004
9. Herweck-Behnsen E. Leistungspflicht der gesetzlichen Krankenversicherung für Arzneimittel, die im Rahmen von Anwendungsbeobachtungen und klinischen Prüfungen, insbesondere Therapieoptimierungsstudien, verordnet oder angewandt werden. Pharma Recht 1997 6 206-212
10. Hoffmeister U, Bullinger M, Egmond-Fröhlich A, et al. [Treatment of obesity in pediatric patients in Germany: anthropometry, comorbidity and socioeconomic gradients based on the BZgA Observational Study]. Klin Padiatr 2010 222 274-278
11. http://www.achse-online.de/
12. http://www.bmbf.de/press/2579.php - 42 K - 11.06.2009
13. http://www.bundesgesundheitsministerium.de/cln-151/nn-1168248/SharedDocs/ Standardartikel/DE/AZ/S/Glossarbegriff-Seltene-Erkrankungen
14. http://www.google.com/search?ie=UTF-8&oe=UTF-sourceid= navclient&gfns=1&q= namse
15. http://www.kiggs.de/experten/erste-ergebnisse/Basispublikation/index.html
16. http://www.kiggs.de/experten/downloads/dokumente/kiggs-elternbroschuere. pdf
17. Ismail-Beigi F, Craven T, Banerji MA, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010 376 419-430
18. Kleber M, Schaefer A, Winkel K, et al. Schulung Obeldicks Mini für adipöse Kinder im Alter von 4 bis 7 Jahren. Klin Padiatr 2009 221 291-295
19. Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr 2010 222 321-326
20. Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: A randomized trial. Medical Care 1999 37 5-14
21. McAlister F A, Lawson FME, Teo KK, et al. A systematic review of randomized trials of disease management programs in heart failure. Amer J Med 2001 110 378-384
22. Rezvanian H, Hashemipour M, Kelishadi R, et al. A randomized, triple masked, placebo-controlled clinical trial for controlling childhood obesity. World J Pediatr 2010 6 317-322
23. Röhrig B, du Prel JB, Blettner M. Study design in medical research: part 2 of a series on the evaluation of scientific publications. Dtsch Arztebl Int 2009 106 184-189
24. Röhrig B, du Prel JB, Wachtlin D, et al. Sample size calculation in clinical trials: part 13 of a series on evaluation of scientific publications. Dtsch Arztebl Int 2010 107 552-556
25. Thiele KP, Rheineberger P. Unmöglich gibt es nicht. Deutsches Ärzteblatt 2003 100 A1044-A1046
26. Thomson Reuters (ISI) Web of Knowledge - Science - Thomson Reuters